Remdesivir
Remdesivir (GS-5734) is a broad-spectrum antiviral nucleoside analog prodrug that inhibits viral RNA-dependent RNA polymerase. It has demonstrated in vitro and in vivo activity against Ebola, SARS, MERS, and SARS-CoV-2 viruses, supporting its research use for coronavirus and filovirus studies.
Product Specifications
CAS Number
1809249-37-3
Product Name Alternative
2019-nCoV, antiviral, COVID-19, DNASynthesis, DNA Synthesis, DNA/RNA Synthesis, infection, inhibit, Inhibitor, MERS-CoV, GS5734, GS-5734, GS 5734, SARSCoV, SARS coronavirus, SARS-CoV, RNA Synthesis, RNASynthesis, Remdesivir
Field of Research
Cell Biology, Infectious Disease & Virology, Molecular Biology, Pharmacology & Drug Discovery
Purity
97.62% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:12.5 mg/mL (20.74 mM) ; DMSO:240 mg/mL (398.29 mM)
Smiles
C (#N) [C@]1 (O[C@H] (COP (OC2=CC=CC=C2) (N[C@H] (C (OCC (CC) CC) =O) C) =O) [C@@H] (O) [C@H]1O) C=3N4C (=CC3) C (N) =NC=N4
Molecular Formula
C27H35N6O8P
Molecular Weight
602.58
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6302859-01 0.1 mL
GNA11, NT (GNA11, GA11, Guanine nucleotide-binding protein subunit alpha-11, Guanine nucleotide-binding protein G(y) subunit alpha) (MaxLight 490)
Sign In for Pricing
View Details